These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Opie LH, Yusuf S, Kübler W. Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332 [Abstract] [Full Text] [Related]
3. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients. Kloner RA, Vetrovec GW, Materson BJ, Levenstein M. Am J Cardiol; 1998 Jan 15; 81(2):163-9. PubMed ID: 9591899 [Abstract] [Full Text] [Related]
5. Dual calcium-channel blocker therapy in the treatment of hypertension. Saseen JJ, Carter BL. Ann Pharmacother; 1996 Jan 15; 30(7-8):802-10. PubMed ID: 8826565 [Abstract] [Full Text] [Related]
6. [Differential therapy with calcium antagonists]. Scholze JE. Herz; 2003 Dec 15; 28(8):754-63. PubMed ID: 14689111 [Abstract] [Full Text] [Related]
7. What, if anything, is controversial about calcium antagonists? Messerli FH. Am J Hypertens; 1996 Dec 15; 9(12 Pt 2):177S-181S. PubMed ID: 8968430 [Abstract] [Full Text] [Related]
14. Calcium antagonists during and after myocardial infarction. Sleight P. Drugs; 1996 Feb 15; 51(2):216-25. PubMed ID: 8808164 [Abstract] [Full Text] [Related]
15. [Are all calcium antagonists alike?]. Bertel O. Schweiz Rundsch Med Prax; 1992 Feb 11; 81(7):164-7. PubMed ID: 1535950 [Abstract] [Full Text] [Related]
16. Do calcium antagonists cause death, gastrointestinal bleeding, and cancer? Kaplan NM. Am J Cardiol; 1996 Oct 15; 78(8):932-3. PubMed ID: 8888668 [Abstract] [Full Text] [Related]
17. [Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension]. Iskenderov BG, Burmistrova LF, Berenshteĭn NV, Lokhina TV. Kardiologiia; 2007 Oct 15; 47(11):44-5. PubMed ID: 18260963 [No Abstract] [Full Text] [Related]
18. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension]. Halawa B. Pol Merkur Lekarski; 1998 Sep 15; 5(27):107-10. PubMed ID: 10101470 [Abstract] [Full Text] [Related]
19. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension]. Iskendeerov BG, Burmistrova LF, Berenshteĭn NV, Abramova GN, Lokhina TV, Shibaeva TM. Klin Med (Mosk); 2006 Sep 15; 84(11):52-6. PubMed ID: 17243612 [Abstract] [Full Text] [Related]
20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C. Curr Med Res Opin; 2003 Sep 15; 19(3):226-37. PubMed ID: 12803737 [Abstract] [Full Text] [Related] Page: [Next] [New Search]